CRYSTAL MICK: Open Payments
NPI 1801566054 · SHENANDOAH, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 11 payments from 9 companies in 2025. Trend: 2023 $130 · 2024 $352 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Qelbree, TRINTELLIX, REXULTI, ZEPBOUND, SPRAVATO, INGREZZA, NUPLAZID, ARISTADA.
Industry payments across IA — which companies pay providers there.
